Last year we reviewed simvastatin,1 which lowers total and low-density-lipoprotein cholesterol (LDL-C) in plasma by competitively inhibiting the rate-limiting enzyme in cholesterol synthesis, HMG CoA reductase, in the liver. Pravastatin (Lipostat – Bristol-Myers Squibb) is a similar drug.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.